Trial Profile
An open-label study of the effect of first-line treatment with Avastin [bevacizumab] combined with irinotecan and 5-fluorouracil on survival in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Mar 2008 Status changed from in progress to completed.
- 08 Jun 2006 New trial record.